Product Information

IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML is a generic product labeled by Cipla USA Inc., priced at $0.0783 per ML under NDC 69097084064. Its NADAC has been published 287 times since May 26, 2021.

FDA first approved this application on Oct 1, 2012. Its Orange Book therapeutic-equivalence code is AN.

IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML

Ipratropium Bromide and Albuterol Sulfate
$0.0783per ML

Strength

2.5; .5 mg/3mL; mg/3mL

Manufacturer

Cipla USA Inc.

NDC

69097084064

Classification

Generic

Dosage Form

SOLUTION

Route

RESPIRATORY (INHALATION)

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202496

FDA Approved

10/1/2012

TE Code

AN

On Market Since

6/1/2020

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has been published 287 times since May 26, 2021, and over the history we have for it it has risen 36.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0783 per ML
All-time high$0.0892 (Mar 12, 2025)
All-time low$0.0558 (Dec 22, 2021)
52-week high$0.0863
52-week low$0.0783
Median price$0.0779
Average price$0.0745
Largest weekly change+14.3% (Mar 20, 2024)
Weeks tracked287
Tracking sinceMay 26, 2021

Price History

1W

-3.1%

1M

-5.8%

3M

-8.4%

6M

-6.7%

1Y

-9.1%

3Y

+7.0%

5Y

+27.9%

All

+36.5%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, manufactured by Cipla USA Inc., is $0.0783 per ML (NDC 69097084064), effective Nov 18, 2026.

How has the price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML changed over time?

Over the history we have for it, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has risen 36.5%. It has been tracked across 287 weekly CMS publications since May 26, 2021.

What are the highest and lowest recorded NADAC prices for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

Since May 26, 2021, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has ranged from a low of $0.0558 (Dec 22, 2021) to a high of $0.0892 (Mar 12, 2025), with a median of $0.0779 per ML.

Are there cheaper alternatives to IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, is $0.0756 per ML — about 3% below IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML.

Who manufactures IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML (NDC 69097084064) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.